Articles & Video
Biotech VC Down 20% in US as Policies Drive Away Foreign Investors, BIO Says
Reforms to a US national security regulation are putting off foreign investors and driving down VC investment in the biotech space by as much as 20 percent, says BIO’s David Thomas.
Investor Survey: US Leads Global Healthcare Innovation, but China to Catch Up by 2025
According to a survey of 53 China-focused life science investors, 79% of the respondents believe the US is the current global leader in innovation for life science while only 15% picked China. But fast forward six years to expectations for 2025, the vote was split evenly between the two countries at about 48% each, a big turnaround.
How sea turtles are essential to success in China
Recent changes in the Chinese regulatory and legal systems have transformed the Chinese life science market. This BIO-Europe panel on “The China Market” covered a lot of territory discussing the market, clinical trials, sophisticated business models, novel science, and the importance of “sea turtles.”
Digital Health: Advancing innovation through technology and strategic partnerships
Insights from investors, biopharma leaders and digital health executives on how to navigate the digital health sector as it transforms every aspect of the pharmaceutical value chain.
Pharma embraces biopartnering at BIO-Europe to address its innovation deficit
Big pharma’s appetite for early preclinical assets continues to grow and now represents the development phase with the most deals and largest total deal value. Consequently, an increasing number of academic institutions are taking the opportunity to showcase their efforts in the academic track at BIO-Europe.
Just do it. Nike showcases Barcelona’s Startup Slam winner
What are the winners of the past BIO-Europe Spring and BIO-Europe's Startup Slam doing? Catch up with some of them and their most recent successes. Starting with Peptomyc’s co-founders Laura Soucek and Marie-Eve Beaulieu.
Continental Shift: 25 Years of European Biotech Trends and New e-book
Explore the major milestones of European biotech. Learn how European biotech emerged from the US shadow, what key events shaped the industry, and how the sector is expected to develop in the forthcoming years.